Tuesday 26 November 2013

ViiV's HIV Drug Recommended for EU Approval


ViiV's HIV Drug Recommended for EU Approval 

read all

here

Thumbnail
ViiV Healthcare, the HIV company established by GlaxoSmithKline and Pfizer in 2009, announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has recommended marketing authorization for Tivicay (dolutegravir) for use in combination with other antiretroviral medicinal products for the treatment of HIV-infected patients. How soon could the drug be approved in the EU? Find out...

FDA Approves Olysio (simeprevir) for Hepatitis C Virus « New Drug Approvals

Monday 25 November 2013

SCRIP Awards 2013 -Best Company in an Emerging Market – Dr Reddy’s Laboratories – India, Novartis’s Bexsero, Best New Drug « New Drug Approvals

Bayer, Onyx win early FDA OK for Nexavar (sorafenib) in thyroid cancer « New Drug Approvals

Otsuka and Lundbeck’s Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe « New Drug Approvals

DAGLUTRIL » All About Drugs

ANDARINE, Male drugs » All About Drugs